News
International collaboration finds 11 new Alzheimer’s genes to target...
University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration to date, which identified 11...
News
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen...
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for...
News
Human skin wound dressings to treat cutaneous ulcers
Researchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment...
News
Takeda and Lundbeck announce FDA approval of Brintellix™
H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly announced that the U.S. Food and Drug Administration (FDA) has approved Brintellix™ (vortioxetine) for...
News
Malaria No More and Novartis launch Power of One,...
Novartis and Malaria No More announced today the debut of the Power of One campaign, encouraging people around the world to help end child deaths...
News
GSK signs a multi-year agreement with BARDA to supply...
GlaxoSmithKline (GSK) plc has announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of...
News
AstraZeneca and Merck enter licence agreement for investigational oral...
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune, a privately-held, Maryland, US-based biologics...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.